BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Obecure 

35 Bezalel Street
Paz Tower, 17th Floor
Ramat Gan    52521  Israel
Phone: 03-7534100 Fax: 03-7515134


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Obecure Achieves Successful Results in Its Proof of Concept Clinical Study Evaluating the Ability of Histalean(TM) to Mitigate Weight Gain Associated With Olanzapine 6/15/2009 9:47:44 AM    More...
Obecure Completes Patient Enrollment for Its Confirmatory Phase IIb Trial with HistaleanTM in Obesity 1/20/2009 11:59:37 AM    More...
Obecure Recruits First Patient in Phase II Obesity Study in Pre-Menopause Women 9/8/2008 8:59:34 AM    More...
Obecure Signs Strategic Agreement with Farmaceutici-Formenti of the Grunenthal Group for Manufacturing and Supply of Betahistine in Europe 4/9/2008 8:23:26 AM    More...
Obecure Phase II Trial Shows Positive Results For Histalean(TM) In Obese Women Under 50 8/30/2007 7:38:00 AM    More...
Obecure Completes Treatment of Patients in Phase II Obesity Trial 6/25/2007 1:32:00 PM    More...
Obecure Initiates Phase II Study to Examine Effect of OBE101 on Plasma Lipids in Patients Treated With Simvastatin 5/16/2007 12:20:56 PM    More...
Obecure Completes Patient Enrollment for Phase II Obesity Trial 4/11/2007 12:35:51 PM    More...
Obecure Initiates Phase II Weight Gain Prevention Study for Patients Taking Zyprexa 3/13/2007 1:24:37 PM    More...
Obecure Recruits First Patient In Phase II Obesity Study 1/24/2007 11:33:48 AM    More...

//-->